Kansas Bioscience Authority

In 2004 was created Kansas Bioscience Authority, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Olathe. The fund was located in North America if to be more exact in United States.

The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2013. Opposing the other organizations, this Kansas Bioscience Authority works on 21 percentage points less the average amount of lead investments. Considering the real fund results, this Corporate Investor is 11 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2014.

Among the most popular portfolio startups of the fund, we may highlight Metactive Medical, Flow Forward Medical, Innara Health. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Kansas Bioscience Authority, startups are often financed by Novartis Venture Fund, Intersouth Partners, MPM Capital. The meaningful sponsors for the fund in investment in the same round are Open Prairie, Middleland Capital, MPM Capital. In the next rounds fund is usually obtained by Serra Ventures, Middleland Capital, Mid-America Angels.

Notable deals

Review

• No reviews are submitted yet.